SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as the community discusses the appointment of Kaz Nejatian, former COO of Shopify, as the new CEO, and the return of co-founders Keith Rabois and Eric Wu to the Board.  The news is sparking excitement and speculation about the company's future direction, with many anticipating a potential short squeeze and a shift towards an AI-first real estate platform.  Overall, the leadership changes are seen as a positive catalyst, injecting fresh energy and expertise into the company.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid heated online discussions, with community members expressing strong opinions and political views. The catalyst appears to be an incident involving political violence, sparking debates about freedom of speech, gun control, and the current political climate. The conversation also touches on broader themes, including social division, extremist ideologies, and the role of political leaders in shaping public discourse.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid reports of a shooting involving conservative figure Charlie Kirk, sparking heated debate and political commentary within the community. Discussions range from the implications of political violence to gun control and broader societal divisions. The incident occurs ahead of CPI data, adding another layer of uncertainty to the market's direction.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a recently filed $300M mixed securities shelf, leading to community debate about potential dilution and the company's financial strategy. Some investors express concern over increasing expenses and the need for funding, while others believe the shelf registration is a strategic move to capitalize on market movements. Amidst the uncertainty, there's discussion around upcoming FDA meeting minutes and their potential impact on the company's regulatory path for its lead drug candidate.

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending amid increasing investor enthusiasm and high trading volume, with the community actively discussing the potential for significant growth and ARR. Positive sentiment is fueled by the CEO's proactive approach and upcoming earnings report, leading to speculation about a continued surge. Some investors suggest the stock is undervalued compared to its AI peers, contributing to the bullish outlook.

Wearable Devices Ltd. engages in the development of a non-invasive neural input technology that allows operation and control of digital devices using subtle finger movements and fingertip pressure. It offers Mudra band, a neutral input wristband. The company was founded by Asher Dahan, Guy Wagner, and Leeor Langer in March 2014 and is headquartered in Yokne'am Illit, Israel.

Wearable Devices Ltd

WLDS is trending due to a recently granted patent for voice and gesture control technology, sparking discussions about potential acquisitions from major tech players like Apple and Meta. Community members are actively debating the stock's valuation, potential buyout prices, and likelihood of a short squeeze, while also weighing the risks of dilution and historical stock behavior. The stock's low float and high volatility are contributing to the intense interest and trading activity.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending amid discussions about a recent offering and its potential impact on investors, with some fearing dilution while others speculate about acquisitions. Community members are debating the company's cash position and the implications for future growth, including possible deals or expansion into new markets. Some are also following developments of the Solana meme coin $KIRK.X

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.

Sharps Technology Inc

STSS is trending due to a recent partnership with Pudgy Penguins to expand its Solana digital asset treasury exposure, sparking community discussions around valuation and potential short squeezes. The stock's low float and high short interest are fueling speculation about significant price movement, with community members actively mapping out potential short versus long battle zones. Community members are closely watching the company's ties to Solana and speculating on future price targets.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to discussions around a proposed offering of convertible senior notes, with some investors viewing it as a strategic move to boost cloud infrastructure and international commerce, while others express concern about potential dilution. The community is debating whether the offering is a sign of financial strength or weakness, and how it will impact the stock's price in the short and long term. Broader market sentiment towards Chinese stocks and their growth potential also contributes to the ongoing conversation.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight bullish chart patterns and strong accumulation, anticipating a potential breakout soon. The community emphasizes the growing strength and organic engagement around the project. Some users are drawing comparisons to Shiba Inu, noting potential connections.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Contrasting Achilles Therapeutics (NASDAQ:ACHL) & DBV Technologies (NASDAQ:DBVT)

Achilles Therapeutics (NASDAQ:ACHL - Get Free Report) and DBV Technologies (NASDAQ:DBVT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast...

Achilles Therapeutics price target lowered by $5 at Chardan, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Piper Sandler gets more bearish on Achilles Therapeutics, downgrades shares

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma Improved VELOS manufacturing process delivering higher cNeT doses Protocols updated...

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

Improved VELOS manufacturing process delivering higher cNeT doses Protocols updated to evaluate the benefit of enhanced host conditioning, with further data expected in 2H 2024 First three...

Reviewing Achilles Therapeutics (NASDAQ:ACHL) & IN8bio (NASDAQ:INAB)

IN8bio (NASDAQ:INAB - Get Free Report) and Achilles Therapeutics (NASDAQ:ACHL - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...

Achilles Therapeutics plc (NASDAQ:ACHL) Sees Large Decrease in Short Interest

Achilles Therapeutics plc (NASDAQ:ACHL  Get Free Report) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling...

Short Interest in Achilles Therapeutics plc (NASDAQ:ACHL) Declines By 79.5%

Achilles Therapeutics plc (NASDAQ:ACHL  Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 10,100 shares, a...

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

LONDON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal...

Achilles Therapeutics plc (NASDAQ:ACHL) Sees Significant Increase in Short Interest

Achilles Therapeutics plc (NASDAQ:ACHL  Get Free Report) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 49,200 shares, an increase of...

Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.

Achilles Therapeutics Plc - ADR

Buying for a long-term investment

Buying for a short-term trade

Trading around the volatility

Avoiding it

$KLAR IPO day is upon us, how are you playing it?

Stocktwits

Klarna Group plc

 IPO day is upon us, how are you playing it?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '24	-$0.36	--	--	N/A
Q3 '24	-$0.41	-$0.48	-17.07%	MISSED
Q2 '24	-$0.41	-$0.41	--	EXPECTED
Q1 '24	-$0.46	-$0.30	35.25%	BEAT
Q4 '23	-$0.14	-$0.46	-217.24%	MISSED

ACHL
Achilles Therapeutics Plc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '24

Historical Earnings

Latest ACHL News

ACHL Achilles Therapeutics Plc - ADR